Where does Imagine Scientific, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Imagine Scientific, Inc. ranks #19,892 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Imagine Scientific, Inc. hold?

Imagine Scientific, Inc. holds 14 US utility patents granted between 2019 and 2025, spanning 6 technology areas.

What is Imagine Scientific, Inc.'s Innovation Score?

Imagine Scientific, Inc. has an Innovation Score of 32.9 out of 100 (43rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Imagine Scientific, Inc. focus on?

Imagine Scientific, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 11 patents, ranking #1,592 of 7,127 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Imagine Scientific, Inc.'s patent grant rate increasing or decreasing?

Imagine Scientific, Inc.'s recent grant velocity is +233% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Imagine Scientific, Inc.'s patents?

Imagine Scientific, Inc.'s patents average 19.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Imagine Scientific, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Imagine Scientific, Inc.

USPTO PatentsView assignee record - 14 granted patents across 6 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Imagine ranks #19,892 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 6 technology areas.

#19,892
of 49,997 US assignees by volume: 43rd percentile
by Innovation Score (32.9/100): 19.8
avg claims per patent: +233%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19892 · US Corporation #19,892 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #19,892/49,997
PHOTO-FINISH Igneous Systems
CPC-NARROW A61B · 6 areas
INNOV-THIN 32.9/100
CLAIMS-RICH 19.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +233% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Igneous Systems, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Imagine’s 32.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (28%) Velocity 3.0 pts (9%) Breadth 8.7 pts (26%) Claim depth 11.9 pts (36%)

Qualcomm Incorporated · highest

85
Imagine Scientific · this assignee

33
3D Lighting… · lowest

7

What this shows Imagine's Innovation Score is 32.9/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Imagine?

Each dot is one of Imagine’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Imagine’s own 19.8 claims/patent is ABOVE the 14.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Imagine vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Imagine's grants concentrate

Imagine Scientific, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 78.6% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (4 grants) versus a trough of 1 in 2022. By volume, Imagine sits between Ixcela, Inc. and IneoQuesto Technologies, Inc..

Imagine's three-year grant acceleration

Imagine Scientific, Inc. shows 4 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ixcela

14
Izumi Products

14
Igneous Systems

14
Ikena Oncology

14
Immutrix Therapeu…

14
Implant Direct Sy…

14
Incelldx

14
Ineoquesto

14
Imagine Scientific ◀

14

What this shows Imagine holds 14 patents at rank #19,918, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Imagine

By rank, the assignees closest to #19,918 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Imagine's primary technology class.

Imagine's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 43rd percentile higher than 43% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Imagine Scientific, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	3	21.4%
2020	4	28.6%
2021	2	14.3%
2022	1	7.1%
2023	2	14.3%
2024	1	7.1%
2025partial year	1	7.1%

Which technologies does Imagine Scientific, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 11

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 11

H01J - Electric Discharge Tubes OR Discharge Lamps 11

H05G - X-ray Technique 9

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

G21K - Techniques FOR Handling Particles OR Ionising Radiation NOT Otherwise Provided FOR; Irradiation DEVICES; Gamma RAY OR X-ray Microscopes 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Imagine Scientific, Inc.'s patent record in context - here's where to go next.

Imagine Scientific, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 78.6% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #19,892 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Imagine Scientific, Inc. against Ixcela, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.